Tag: Merck

JHVEPhoto/iStock Editorial through Getty Photographs Merck (NYSE:MRK) is ceasing improvement of two monoclonal antibody candidates it was eying as fixed-doses ...

MilliporeSigma, a Merck unit, has opened its new $317.2 million biosafety testing facility in Rockville, Md. Developed by Alexandria Actual ...

© Reuters. FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, ...

Sundry PhotographyInvestors of Biopharma leader Merck & Co., Inc. (NYSE:MRK) didn't cheer the completion of its recent $10.8B acquisition of ...

Dow Jones futures and S&P 500 rose slightly Monday morning, while Nasdaq futures edged lower. Merck announced a sizeable biotech ...

Kameleon007/iStock via Getty Images Merck (NYSE:MRK) and Moderna (NASDAQ:MRNA) presented detailed mid-stage results for a combination therapy containing vaccine maker’s ...

koto_feja/iStock via Getty Images Merck (NYSE:MRK) and Eisai (OTCPK:ESALF) (OTCPK:ESAIY) announced Friday that the companies would halt two late-stage combination ...

© Reuters. FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, ...

Merck & Co. and Glenmark Pharmaceuticals Ltd. are expected to face a jury trial in a five-year-old case about alleged ...

From Reuters:https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-merck-vaccine-combo-cut-melanoma-recurrence-by-44-study-2022-12-13/In a mid-stage trial, looks like the mRNA cancer vaccine from Moderna coupled with Merck's immuntherapy drug cut recurrence ...